Seeing Is Believing
Currently out of the existing stock ratings of Prakhar Agrawal, 47 are a BUY (92.16%), 4 are a HOLD (7.84%).
Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 41.16% that have a potential upside of 46.43% achieved within 125 days.
Prakhar Agrawal’s has documented 93 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GPCR, Structure Therapeutics American Depositary Shares at 23-Jun-2025.
Analyst best performing recommendations are on NEXI (NEXIMMUNE).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/14/2022. The price target of $36 was fulfilled within 27 days with a profit of $16.39 (83.58%) receiving and performance score of 30.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Feb-2022
$100
$0.01 (0.01%)
$120
4 years 15 days ago
(09-Feb-2022)
3/5 (60%)
$6.56 (7.02%)
256
Hold Since 22-Dec-2021
$100
4 years 1 months 28 days ago
(27-Dec-2021)
4/6 (66.67%)
$9.27 (10.22%)
204
Hold Since 15-Dec-2021
$100
$0.01 (0.01%)
$104
4 years 2 months 9 days ago
(15-Dec-2021)
0/2 (0%)
$7.15 (7.70%)
Hold Since 15-Dec-2021
$100
$0.01 (0.01%)
4 years 2 months 9 days ago
(15-Dec-2021)
3/4 (75%)
$7.15 (7.70%)
557
Hold Since 15-Dec-2021
$100
$0.01 (0.01%)
$76
4 years 2 months 9 days ago
(15-Dec-2021)
5/6 (83.33%)
$7.15 (7.70%)
448
What Year was the first public recommendation made by Prakhar Agrawal?